Two experiments were conducted to determine whether administering a dopamine antagonist to steers fed endophyte-infected (E+) tall fescue would increase serum prolactin (PRL) and reduce rectal temperature. Steers in both experiments were housed in environmentally controlled chambers (32°C; 50% relative humidity). In Exp. 1, 10 steers were allotted randomly to receive s.c. injections of either 0, .006, .03, or .06 mg of Ro 24-0409 (dopamine antagonist)/kg BW. The experiment was designed in four phases: endophyte-free seed ( E−) without antagonist ( d −11 to 0); E− with antagonist ( d 0 to 7); E+ with antagonist ( d 7 to 28); E+ without antagonist ( d 28 to 38). In Exp. 2, 22 Holstein steers were allotted randomly to the same treatments and design, except three steers were maintained on E− without antagonist. Steers were fed individually with intakes measured daily. In Exp. 1, feed intake and rectal temperature were not improved ( P > .05) by antagonist injection. In Exp. 2, antagonist injections increased ( P < .05) PRL. Ingestion of E+ decreased ( P < .05) feed intake and serum PRL. Antagonist injection decreased ( P < .05) rectal temperature and increased ( P < .05) serum PRL.
Introduction
Cattle, sheep, and horses are negatively affected by fescue toxicosis. Tall fescue containing the endophytic fungus Acremonium coenophialum (Morgan-Jones and Gam, 1982) has been found to produce ergot peptide alkaloids (Yates et al., 1985; Belesky et al., 1988) . These ergot peptide alkaloids are believed to cause the symptoms of fescue toxicosis. Symptoms include decreased circulating serum prolactin ( PRL) levels (Schillo et al., 1988; Boling et al., 1989) , feed intake, daily gain (Schmidt et al., 1982) , blood flow to the periphery , and conception rates, and increased core body temperature (Schmidt et al., 1982) . Therapeutic treatment with various dopamine antagonists has been shown to increase serum PRL levels, suggesting a partial reduction in the negative influence of fescue toxicosis (Boling et al., 1989; Lipham et al., 1989; Aldrich et al., 1993) . Piquindone, a dopamine antagonist, increased serum PRL levels but had no effect on feed intake and rectal temperatures (Rhodes, 1991) . When the Piquindone derivative Ro 24-0409 was injected i.v. into steers, serum PRL increased (Rhodes, 1991) , and i.p. injection in rats increased skin temperatures (Larson et al., 1993) .
The objective of this study was to determine whether the dopamine antagonist Ro 24-0409, a pyrroloisoquinoline derivative, would alleviate the signs in steers with fescue toxicosis.
Materials and Methods

Experiment 1. Ten Holstein steers (average BW 117
± 29.7 kg) were allotted to treatments and allowed an 11-d ( d −11 to 0 ) adjustment period in the Brody Climatology Chambers at the University of Missouri Hoffmann-LaRoche, Nutley, NJ) with concentrations of 0 ( n = 2), .006 ( n = 3), .03 ( n = 3), or .06 ( n = 2 ) mg/kg BW. Steers allotted to the 0 mg/kg BW antagonist received a placebo injection of the saline carrier (.5 mL). On d 7, the diet was changed to contain 10% endophyte-infected tall fescue seed ( E+; 370 ppb ergovaline) and continued until d 38 (Table  1) . Feed offered and refusals were recorded daily. Twice weekly, skin and rectal temperatures were recorded beginning 1 h before drug administration and measured every minute thereafter for 9 h. Rectal temperatures were recorded with probes placed approximately 10 cm within the rectum. Probes were 15.34 cm in length excluding the shoulder, .48 cm in diameter, and made of stainless steel with a 100-Ohm platinum RTD-sensor. Probes were attached to the tailhead at the shoulder of the probe using elastic tape. Skin temperature probes were 3.49 cm in diameter with the 100-Ohm RTD-sensor encapsulated in stainless steel. The skin probe was attached to a shaved area on the tailhead using glue placed around the edge of the probe. Temperature probes were attached to the animals approximately 50 min before the first reading to allow for equilibration. Skin and rectal temperature measurements were averaged over each hour.
On d 0, 7, 14, 21, 28, and 38, steers were bled via jugular catheterization. Catheters were placed in steers on d −9 and maintained until d 28. All catheters were removed on d 28 and replaced on d 37. Catheters that required replacement were returned the day before collection of blood. Collection of blood began 1 h after dosing of dopamine antagonist and continued every 30 min for 2 h. Blood was collected into 10-mL syringes, transferred to test tubes, covered, and allowed to sit at room temperature for 2 h. After blood was collected from catheters, heparinized saline was injected into the catheter. Blood was placed in a refrigerator overnight, removed and allowed to reach room temperature, and then centrifuged for 15 min at 2,000 × g. Serum was stored ( −20°C ) until it was analyzed for PRL by double antibody RIA (Spoon and Hallford, 1989) .
All data were subjected to analyses of variance using the GLM procedure of SAS (1985) . Feed intake, PRL, and skin and rectal temperature data were analyzed using split-plot analyses of variance for repeated measures with treatments (antagonist injection) in the main plot and phase in the subplot (Gill and Hafs, 1971) .
Experiment 2. The objective of the second experiment was to verify the results that Ro 24-0409 reduced some signs of fescue toxicosis. Twenty-two Holstein steers (average BW 113 ± 14.9 kg) were allotted to treatments and allowed an 11-d ( d −11 to 0 ) adjustment period in the Brody Climatology Chambers at the University of Missouri (constant temperature of 30°C; 60% relative humidity; 16:8 light:dark photoperiod). Steers were fed twice daily a diet containing 20% E− from d −11 to 7 (Table 2) . Beginning on d 0 and continuing until d 28, steers received s.c. injections of Ro 24-0409 at the same time of day with concentrations of 0 ( n = 8), .006 ( n = 5), .03 ( n = 5), or .06 ( n = 4 ) mg/kg BW. Steers injected with 0 mg/kg BW received placebo injections of the saline carrier (.5 mL). On d 7, the diet was changed to contain either E− receiving the placebo injection ( n = 3 ) or E+ (125 ppb ergovaline) with various levels of drug injections. Feed intakes and refusal were measured daily.
On d 0, 7, 14, 21, 28, and 38, calves were bled via jugular venipuncture. Collection of blood began 1 h after dosing of dopamine antagonist and continued every 30 min for 2 h. Blood was collected into sterile serum tubes, allowed to clot at room temperature (60 min), and then centrifuged for 15 min at 2,000 × g. Serum was stored ( −20°C ) until it was analyzed for PRL by double antibody RIA (Spoon and Hallford, 1989) . A single rectal and skin temperature was recorded weekly 8 h after injection. Rectal temperatures were recorded using a Fisher hand-held thermometer with the probe placed approximately 10 cm within the rectum. Skin temperature was measured using an infrared thermometer (Everest Interscience, Fullerton, CA). Skin temperature was taken on a shaved area on the tailhead of the steer.
All data were subjected to analyses of variance using the GLM procedure of SAS (1985) . Serum PRL levels, feed intake, and rectal and skin temperature were analyzed using split-plot analyses of variance for repeated measures with treatment (antagonist injection) in the main plot and phase in the subplot (Gill and Hafs, 1971) . Differences among treatment means were detected using Student-Newman-Keuls procedure (SAS, 1985) .
Results and Discussion
Experiment 1. There were no differences in feed intake due to administration of the antagonist ( Figure  1 ). Prolactin levels ( Figure 2 ) were increased due to dopamine antagonist administration. A treatment × phase interaction ( P = .007) but no treatment × time (hour) interaction occurred. On d 0 and 7, PRL levels were similar ( P > .05). When E+ was consumed, steers that received no antagonist had a sharp decrease ( P < .05) in PRL level, indicating fescue toxicosis. The two highest levels of antagonist injection increased ( P < .05) PRL to E− levels. After antagonist injections ceased on d 28, PRL levels in all steers declined.
There was no treatment × time interaction ( P > .10) for rectal or skin temperatures. Rectal temperatures ( Figure 3 ) were not different ( P > .05) among treatments. Skin temperatures (Figure 4 ) were similar ( P > .10) when steers consumed E− diets. When E+ diets were fed, steers injected with the lowest level of antagonist had increased ( P < .05) skin temperatures compared to the other three treatments. However, this was unchanged from E− consumption. Skin temperatures were similar ( P > .10) when E+ was consumed and injections ceased. Increasing skin temperature, as occurred for the lowest antagonist injection, is an indication of the animal's ability to dissipate body heat.
Steers that received placebo had decreased serum PRL. Steers injected with the two highest antagonist levels had increased PRL levels when consuming E+ as compared to steers consuming E+ with placebo injection. When antagonist administration ceased, steers that received antagonist injection consequently exhibited diminished PRL levels.
Experiment 2. When steers were fed E− with no injections, feed intake was similar ( P > .05) among treatments ( Figure 5 ). Antagonist injection into steers fed the E− diet decreased ( P < .05) feed intake. When E+ feeding began, feed intakes were improved ( P < .05) only for steers on the antagonist treatment. However, feed intakes were similar ( P > .05) for all antagonist levels (not different from controls) and less ( P < .05) than intake of E− diets. When injections ceased, feed intake increased in steers that received .06 mg/kg BW antagonist over the placebo, but intake was not as great as for steers consuming E−. We speculated that compensatory feed intake may have occurred in steers receiving the high levels of antagonist.
Serum PRL concentrations ( Figure 6 ) were similar ( P > .05) among treatments when steers were fed E− both before and during antagonist injections. Endophyte ingestion decreased ( P < .05) PRL in all treatments except E− injected with placebo and the highest antagonist level, which were both similar ( P > .05). The decrease in serum PRL indicated that steers fed E+ experienced fescue toxicosis (Boling et al., 1989) and that dopamine antagonist injection could increase serum PRL levels to E− levels. When antagonist injections ceased, steers consuming E+ had similar ( P > .05) PRL levels, and PRL concentrations were drastically reduced ( P < .05) when compared with those for steers consuming E−. There seemed to be no residual effect of the dopamine antagonist on serum PRL levels.
The increase in serum PRL in both experiments agrees with Rhodes (1991) , who demonstrated that Ro 24-0409 increased serum PRL levels in Holstein steers. In Exp. 1, steers injected with .03 and .06 mg/ kg BW antagonist while consuming E+ had similar PRL levels. In Exp. 2, steers injected with .06 mg/kg BW had higher PRL levels than steers injected with .03 mg/kg BW while consuming E+. The variation between experiments may be explained by differences in the animals or the ergovaline level consumed by the steers. Increased PRL has been reported by other researchers using other dopamine antagonists (Bolt et al., 1987; Boling et al., 1989; Lipham et al., 1989) , but Ro 24-0409 seems also to alter the animal's ability to dissipate body heat.
Because there were no effects due to hour of sampling in the first experiment, skin and rectal temperatures were measured once a week throughout the experiment. Rectal temperatures ( Figure 7 ) were different ( P < .05) among treatments when E− was fed to all steers and injected with dopamine antagonist. Steers fed E− with placebo injection and steers injected with 0, .006, or .06 mg/kg BW antagonist had similar ( P > .05) rectal temperature. When fed E+, steers injected with .03 or .06 mg/kg BW antagonist had the lowest ( P > .05) rectal temperatures. Steers fed E+ with 0 mg/kg BW drug injection and steers fed E− had similar ( P > .05) rectal temperature. Steers fed the E− diet had rectal temperatures similar ( P > .05) to those of steers injected with .006 mg/kg BW antagonist. When injections ceased, there were no differences ( P > .05) in rectal temperatures among treatments. Larson et al. (1993) reported increased skin temperatures in rats injected with Ro 24-0409, but rectal temperatures were unaffected. These results were similar to Exp. 1 in which Holstein steers had increased skin temperatures when injected with .03 mg/kg BW but rectal temperatures remained unchanged. In Exp. 2, however, no differences ( P > .05) occurred in skin temperature among treatments (data not shown).
Body temperature, both skin and rectal, is related to the animal's ability to alter peripheral blood flow and heat dissipation. Increased skin temperature in the absence of a change in core temperature indicates that blood flow may be increasing to the skin and potentially increase heat dissipation. Decreased rectal temperature may indicate body heat was removed from the core of the body and dissipated to the environment. Steers consuming E+ with 0 mg/kg BW antagonist had signs of fescue toxicosis (i.e., increased rectal temperatures and decreased serum PRL levels). Injection of .06 mg Ro 24-0409/kg BW increased serum PRL to control levels and only slightly increased rectal temperature compared with placebo. Injection of .03 mg/kg BW increased serum PRL level and maintained rectal temperature increases to below E−. Administration of the dopamine antagonist Ro 24-0409 may potentially reduce severity of fescue toxicosis.
Implications
The dopamine antagonist Ro 24-0409 alleviated some signs of fescue toxicosis. This implied that the D 2 dopaminergic receptors are a logical site for therapeutic and(or) prophylactic treatment. However, other receptor sites must be considered because this dopamine antagonist did not return feed intakes to levels demonstrated by steers fed endophyte-free fescue seed.
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